Fact checked byChristine Klimanskis, ELS

Key takeaways:

• Home OCT may help patients achieve extended dosing intervals through consistent fluid evaluation.
• Scans are reviewed by AI through a cloud-based platform and by the ophthalmologist.

FORT LAUDERDALE, Fla. — Home OCT offers personalized insights on treatment response for wet age-related macular degeneration that may help reduce treatment burden, according to a speaker.

While second-generation anti-VEGF agents allow for extended dosing intervals longer than what is on label for many patients, not all patients can be extended, Judy E. Kim, MD, FARVO, FASRS, said at the Retina World Congress.

“When a patient is switched from first generation to second generation or even within second generation, we do not know how long they can be extended, and they do not last as long as treatment-naive patients,” she said. “Finally, when we do these extensions, what about the other eye?”

Read more: rb.gy/1d7qym

Source: Healio